• Title/Summary/Keyword: Probiotic yeast

검색결과 59건 처리시간 0.025초

Effects of Bacillus polyfermenticus SCD Administration on Fecal Microflora and Putrefactive Metabolites in Healthy Adults

  • Park, Kyu-Yong;Jung, Hwang-Yeong;Woo, Kang-Lyung;Jun, Kyoung-Dong;Kang, Jae-Seon;Paik, Hyun-Dong
    • Journal of Microbiology and Biotechnology
    • /
    • 제12권4호
    • /
    • pp.657-663
    • /
    • 2002
  • Probiotics have been suggested to improve gastrointestinal health in humans. To investigate the effects of Bacillus polyfermenticus SCD administration on fecal microflora and putrefactive metabolites in humans, Bacillus polyfermenticus SCD (4.00${\times}$10$\sub$5/ CFU/mg) was administrated to ten healthy subjects (5 men and 5 women, average age 24 years) three times a day for 2 weeks. Fecal samples were collected before (1st and 2nd weeks, control), during (3rd and 4th weeks), and 2 weeks after the administration. The fo11owing microbial groups were evaluated in the feces: aerobic and anaerobic bacteria, Bacillus polyfermenticus SCD, Lactobacillus, Bifidobacterium, total lactic acid bacteria, Salmonella, Clostridium, Clostridium perfringens, Eubacterium, Staphylococcus, Coliform bacteria, Pseudomunas, and Yeast. Fecal concentrations of total aerobic bacteria (p<0.05, p<0.01, 3rd and 4th weeks), total lactic acid bacteria (p<0.01, 3rd, 4th and 5th weeks), and Bifidobacteria (p<0.05, 4th and 5th weeks) were significantly increased in all subjects, compared to the control, from the 3rd week after the administration of the products. Clostridium (p<0.01, 4th week), Clostridium perfringens (p<0.05, p<0.01, 3rd and 4th weeks), and coliform (p<0.01,5th week) were significantly reduced from the 3rd week of administration. No significant changes in the fecal concentrations of Pseudomonas, Lactobacillus, Eubacterium, Staphylococcus, yeast, and total anaerobes were observed. Six weeks after the administration, the concentration of all rnicroorganlsrns returned to the basal level. Bacillus polyfermenticus SCD was significantly maintained from the 3rd week to 6th week of the study. Despite the absence of a statistical significance, the putrefactive metabolites (ammonia, indole, skatole, and $\rho$-cresol) and the pH value tended to be lower during and after the test periods than the base line. These results show that this probiotic preparation is able to colonize the intestine, and suggest that it may be useful as a beneficial probiotic in humans.

스타터로 사용한 Probiotics-효모 비율을 달리하여 제조한 Sourdough 제빵특성 (Sourdough and Bread Properties Utilizing Different Ratios of Probiotics and Yeast as Starters)

  • 채동진;이광석;장기효
    • 한국식품과학회지
    • /
    • 제43권1호
    • /
    • pp.45-50
    • /
    • 2011
  • 혼합 probiotics 균과 제빵용 효모의 비를 각각 2.0:0.1, 1.5:0.1, 1.0:0.1(g/g)로 다르게 하였을 때, 다음과 같은 결과를 도출하였다. Sourdough starter의 probiotics 균의 생균수는, 발효 초기와 비교 시, 25시간 발효한 후의 생균수가 Exp 2에서는 약 130배 가까이 증가하여 다른 두 군에 비해 가장 많이 증가하였다. Sourdough starter의 pH는 전반적으로 4.1-4.4의 범위에 있어 세 군 모두 sourdough starter로 사용하기에 적당한 수치였으며, TTA는 측정결과 Exp 2군이 가장 많이 증가하였다. Sourdough starter의 발효율은 Exp 2에서 165 mL로 세 군 중에서 가장 높게 나타났다. CrumbScan의 영상분석의 결과는 Exp 2의 부피가 2,332 mL로 세군 중에서 가장 큰 것으로 나타났고, 기공의 조밀도는 유의적인 차이를 보이지 않았으며, 기공의 찌그러짐의 정도는 Exp 1에 비해 Exp 2와 Exp 3에서 1.44로 높았다. Sourdough starter와 sourdough bread의 향 성분 분석결과는, 반죽과 빵의 향 조성은 매우 다르게 나타났으나, 각각의 starter를 이용하여 sourdough bread를 제조한 후, 향성분의 변화를 살펴보면 sourdough starter에서의 주요향성분과 동일하였다. 식빵의 속질 색에 대한 관능평가에서는 전반적으로 보통의 정도로 나타났고 유의적인 차이가 없었다. Exp 2에서 기공의 상태가 가장 균일하였고, 촉감에서도 가장 부드러웠다. 그리고 향, 맛 및 전체적인 품질 평가에서도 Exp 2의 선호도가 유의적으로 높게 나타났다. 결과적으로, sourdough starter Exp 2 조성으로 제조한 sourdough bread가 모든 항목에서 가장 높게 평가되었다.

Effects of Mannan-oligosaccharides and Live Yeast in Diets on the Carcass, Cut Yields, Meat Composition and Colour of Finishing Turkeys

  • Konca, Yusuf;Kirkpinar, Figen;Mert, Selim
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제22권4호
    • /
    • pp.550-556
    • /
    • 2009
  • This study was designed to evaluate the effects of dietary prebiotic (mannan oligosaccharide = MOS) and probiotic (Saccharomyces cerevisiae = SC) in finishing turkey diets on carcass, cut yield, meat composition and colour. A total of 72 ten-weeksold Big6 male turkey poults were used in the trial. There were eight replicate floor pens per floor with three birds in each. The experiment lasted up to 20 wks of age. The trial was set up as a completely randomized design with 3 dietary treatments. The treatments were: i) negative control (C, no additive); ii) MOS 1 g per kg of diet and iii) SC 1 g per kg of diet (strain SC47, $300{\times}10^{10}$ CFU/kg). Body weight (BW) and feed intake were determined for each of the two week intervals. Twenty-four birds were slaughtered and eviscerated to determine carcass, carcass parts and internal organ weights at 20 wks of age. Meat colour and pH levels were measured 24 h after slaughter. The dietary treatments did not affect BW and average daily gain during the trial (p>0.05). The average daily feed intake and feed conversion ratio of turkey toms fed with MOS were higher than those of control and SC groups during the overall period (p<0.05). The dietary treatments did not affect carcass yield, breast meat, thigh, wing, liver, heart, empty gizzard, intestine, and abdominal fat pad proportions and meat pH, composition and pigmentation (p>0.05). These results suggest that the addition of MOS and SC is not likely to produce any performance or carcass characteristics in finishing turkeys at 10 to 20 wks of age.

Effect of Different Commercial Oligosaccharides on the Fermentation Properties in Kefir during Fermentation

  • Oh, Nam Su;Lee, Hyun Ah;Myung, Jae Hee;Lee, Ji Young;Joung, Jae Yeon;Shin, Yong Kook;Baick, Seung Chun
    • 한국축산식품학회지
    • /
    • 제33권3호
    • /
    • pp.325-330
    • /
    • 2013
  • Kefir is traditional fermented milk produced by various lactic acid bacteria (LAB) and yeast, which produce lactic acid, ethanol, carbon dioxide, and other flavor compounds. The purpose of this study was to evaluate the effects of different commercial oligosaccharides, such as maltotriose, fructooligosaccharide (FOS), galactooligosaccharide (GOS), and isomaltooligosaccharide (IMO), on the fermentation properties of kefir. First, we determined the acidification kinetic parameters, such as $V_{max}$, $t_{max}$(h), $t_{pH5.0}$(h), and $t_f$(h) of fermented milk supplemented with 4% (w/w) of different oligosaccharides. The probiotic survival and chemical composition (pH, organic acids profile, and ethanol content) of kefir during fermentation were also measured. Compared to control fermentation, all oligosaccharides increased acidification rate and reduced the time to complete fermentation (pH 4.7). The addition of FOS, in particular, resulted in the lowest $t_f$(h) and the highest populations of LAB and yeast during fermentation. All oligosaccharides increased ethanol production during fermentation. Further, significant differences were observed in the formation rates of six organic acids during fermentation. This study provided comparative data on the properties of commercial oligosaccharides for kefir manufacturing. Consequently, FOS especially had the potential for adequate and effective oligosaccharides in commercial kefir for the improvement of cost- and time-effectiveness.

Investigation of the impact of multi-strain probiotics containing Saccharomyces cerevisiae on porcine production

  • Sheena Kim;Jinho Cho;Gi Beom Keum;Jinok Kwak;Hyunok Doo;Yejin Choi;Juyoun Kang;Haram Kim;Yeongjae Chae;Eun Sol Kim;Minho Song;Hyeun Bum Kim
    • Journal of Animal Science and Technology
    • /
    • 제66권5호
    • /
    • pp.876-890
    • /
    • 2024
  • A balanced intestinal microbiome controls intestinal bacterial diseases, helps regulate immunity, and digests and utilizes nutrients, ultimately having a positive effect on the productivity of industrial animals. Yeasts help in the digestion process by breaking down indigestible fibers and producing organic acids, vitamins, and minerals. In particular, polysaccharides such as beta-glucan and mannan-oligosaccharides, which are present in the cell wall of yeast, inhibit the adhesion of pathogens to the surface of the gastrointestinal tract and increase resistance to disease to help maintain and improve intestinal health. Among the yeast additives used in animal feed, Saccharomyces cerevisiae is one of the most commonly used probiotics. However, it does not naturally reside in the intestine, so if it is supplied in combination with other species of probiotics that can compensate for it, many benefits and synergies can be expected for pigs in terms of maintaining intestinal health such as supplementing the immune system and improving digestion. A number of previous studies have demonstrated that dietary complex probiotic supplementation has growth-promoting effects in pigs, suggesting that multiple strains of probiotics may be more effective than single strain probiotics due to their additive and synergistic effects. In practice, however, the effects of complex probiotics are not always consistent, and can be influenced by a variety of factors. Therefore, this review comprehensively examines and discusses the literature related to the effects of complex probiotics using Saccharomyces cerevisiae in pig production.

박테리오신 OR-7을 생산하는 항균 효모의 양계에서의 사양시험 효과 (Efficacy of Antibacteriocidal Yeast That Producing Bacteriocin OR-7 in Chicken)

  • 조동인;강상모;이재화;이상현;김남영;김기석
    • 한국미생물·생명공학회지
    • /
    • 제38권4호
    • /
    • pp.391-398
    • /
    • 2010
  • 산란계에서 본 연구의 목적은 생균제(PY0.3%, PY0.5%) 를 산란계에 급여하였을 때 산란율, 산란수, 난중, 등외란, 파란율 등을 조사하기 위하여 실시하였다. 산란계에서의 사양시험은 36주령 ISA brown 산란계 300수를 공시하였으며, 처리구로는 옥수수-대두박 기초 사료구(Con; basal diet), 기초 사료구에 일반 효모 0.3%(basal diet+0.3% 일반효모), 일반 효모 0.5%(basal diet+0.5% 일반효모), 활성 효모 0.3%(basal diet+0.3% 유전자 변형 효모), 활성 효모 0.5%(basal diet+0.5% 유전자 변형 효모)를 첨가한 것으로 구성되었다. 총 13주간의 사양시험 기간 동안, 산란율, 산란수, 난중, 등 외란, 파란율 등을 연구했다. 사양시험에 이용한 닭은 각각 20수씩 3반복을 하였으며, 총 300수를 사용했다. 시험결과 시험군인 활성 효모 첨가군이 대조군에 비해서 산란율, 산란수, 난중에서 우수한 효과를 보였으며, 일반효모 첨가군에 비해서는 산란율, 산란수에 대해서는 우수하였으나 난중에서는 유의성이 없었다(p<0.05). 등외란과 파란율에서는 첨가 군에서 큰 란이 생산되는 비율이 크다 보니까 상대적으로 등 외란과 파란율이 높아진 면도 있다. 이러한 우수한 결과는 PY를 첨가함으로써 면역 기능강화와 bacteriocin의 기능과 효모에서 분비된 여러 가지 유용물질의 상호작용에서 기인된 결과로 보여 지며 이런 이유로 사료효율 개선과 병원성 미생물의 억제효과 등이 복합적으로 작용하여 상승효과로 작용했기 때문이라고 추정된다.

Studies of the Microbial and Physical Properties of Oriental Style Dairy Product Kou Woan Lao with Probiotics

  • Su, Lieh-Chi;Lin, Chin-Wen;Chen, Ming-Ju
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제18권3호
    • /
    • pp.409-413
    • /
    • 2005
  • The objective of this research was to combine the physiological functionality of probiotics (Lactobacillus acidophilus and Bifidobacterium longum) and the milk-clotting activity of culture filtrate from lao-chao to develop a new dairy product which was different from the commercial yogurt. Rhizopus javanicus and Saccharomyces cerevisiae were chosen as a mold and yeast starter for production of culture filtrate. The study results indicated that both probiotic counts increased with incubation time and maintained $10^7$-$10^8$ CFU/ml after 6 h incubation with 10-30% culture filtrates. By contrast, samples with 40% culture filtrates inhibited the growth of L. acidophilus and B. longum. The more culture filtrates were added, the lower titratable acidities and higher pH values in Kou Woan Lao were detected after 36 h fermentation. No significant differences (p>0.05) were found for both L. acidophilus and B. longum, when grown in differing concentrations of skim milk powders. Storage results showed both L. acidophilus and B. longum exhibited excellent stability for 14 days at $4^{\circ}C$ in the Kou Woan Lao.

A Comparison of Feeding Multi-Probiotics and Fermented Ginseng Byproducts on Performance, Intestinal Microflora and Immunity of Broiler Chicks

  • Hassan, Md. Rakibul;Choe, Ho Sung;Ryu, Kyeong Seon
    • 한국가금학회지
    • /
    • 제39권4호
    • /
    • pp.253-260
    • /
    • 2012
  • This study was undertaken to investigate the influence of multi-probiotics, fermented ginseng byproducts and fermented sulfone as an alternative to probiotics on performance, intestinal microflora and immunity of broiler. A five weeks trial was conducted with one day old Ross${\times}$Ross broilers (n=340), divided into five groups which further divided into 4 replicates with 17 birds in each replicate. Birds were assigned to 5 dietary treatments as control, antibiotic avilamycin (AB), multi-probiotics (MP), fermented sulfone (FS) and fermented ginseng byproducts (FGB). Growth parameters were recorded on weekly basis while rest of the parameters viz. blood and faeces were collected at the end of the experiment. Growth parameters were not affected statistically by dietary treatments. However, numerically, higher body weight, splenocytes proliferation and lower total cholesterol and LDL values were found in MP treatment (P>0.05). Salmonella spp. count ($P{\leq}0.001$) and E. coli (P<0.001) concentrations in the ileum were found lowest in AB treatment while FS group showed lowest level of yeast (P<0.10) and Lactobacillus spp. ($P{\leq}0.001$). Fecal ammonia and $CO_2$ emission was significantly decreased in FGB than other dietary treatments (P<0.05). It was concluded that multi-probiotics would be valuable feed additives to improve the growth performance, Lactobacillus proliferation and immunity of broiler chicks.

Occurrence of Glutathione Sulphydryl (GSH) and Antioxidant Activities in Probiotic Lactobacillus spp.

  • Yoon, Yung H.;Byun, Jung R.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제17권11호
    • /
    • pp.1582-1585
    • /
    • 2004
  • The antioxidative ability on the basis of reduced glutathione sulphydryl level, the inhibition activities of linoleic acid peroxidation of cell free extract of Lactobacillus spp. and the effects of types of media and growth phase of the cells on the cellular GSH level have been determined. Correlation between reduced glutathione sulphydryl level and antioxidative ability of Lactobacillus spp. was analyzed: Lactobacillus casei HY 2782 contained 25.15 $\mu$mole/g of GSH, the cellular GSH level of L. casei HY 2782 reached maximum after 24 h of cultivation and tended to decrease on further cultivation up to 72 h. There was a significantly higher level of cellular GSH when grown in de Man Rogosa and Sharpe (MRS) broth than in tryptone phytone yeast extract (TPY) broth or bromcresol pruple dextrose (BCP) broth (p<0.05). The antioxidant activity of cell free extract of Lactobacillus spp. have been shown to be significantly different among strains in the inhibition of linoleic acid peroxidation by thiobarbituric acid (TBA) test (p<0.01). L. casei HY 2782 and L. acidophilus ATCC 4356 revealed a high degree of antioxidative effect in linoleic acid oxidation system. Spearmans' rank correlation coefficient between inhibitory activity on linoleic acid peroxidation and cellular GSH levels of Lactobacillus spp. was 0.65, which means a significant positive correlation.

Role of Probiotics in Human Gut Microbiome-Associated Diseases

  • Kim, Seon-Kyun;Guevarra, Robin B.;Kim, You-Tae;Kwon, Joongi;Kim, Hyeri;Cho, Jae Hyoung;Kim, Hyeun Bum;Lee, Ju-Hoon
    • Journal of Microbiology and Biotechnology
    • /
    • 제29권9호
    • /
    • pp.1335-1340
    • /
    • 2019
  • Probiotics, including bacteria and yeast, are live microorganisms that have demonstrated beneficial effects on human health. Recently, probiotic bacteria are constantly being studied and their applications are also being considered in promising adjuvant treatments for various intestinal diseases. Clinical trials and in vivo experiments have extended our current understanding of the important roles that probiotics play in human gut microbiomeassociated diseases. It has been documented through many clinical trials that probiotics could shape the intestinal microbiota leading to potential control of multiple bowel diseases and promotion of overall wellness. In this review, we focused on the relationship between probiotics and the human gut microbiota and its roles in gut microbiome-associated diseases. Here, we also discuss future directions and research areas that need further elucidation in order to better understand the roles of probiotics in the treatment of intestinal diseases.